{
  "prompt_id": "stage_c_03",
  "stage": "C",
  "generated_at": "2026-01-23T12:46:04.296790Z",
  "metrics": {
    "tool_routing": {
      "score": null,
      "details": {
        "expected": [],
        "observed": [],
        "missing": [],
        "extra": [],
        "note": "no_expected_tools"
      }
    },
    "citation_validity": {
      "score": 0.0,
      "details": {
        "total_count": 0,
        "scholarly_count": 0,
        "guideline_count": 0,
        "portal_count": 0,
        "other_count": 0,
        "malformed_count": 0
      },
      "citations": []
    },
    "fallback_robustness": {
      "score": 0.0
    },
    "rag_fidelity": {
      "score": 0.6666666666666666,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 0.5,\n  \"rationale\": \"The response provides general best-practice guidance for AI-driven cancer research, including realistic timelines, experimental designs, and data sources, without fabricating specific claims. However, it lacks grounding in cited evidence—no actual studies, papers, or concrete data from PubMed, arXiv, or clinical databases are referenced, despite mentioning them. The plan is plausible and aligned with domain knowledge but is not synthesized from specific retrieved evidence, as no web search or RAG was performed (as noted in the response).\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response provides general best-practice guidance for AI-driven cancer research, including realistic timelines, experimental designs, and data sources, without fabricating specific claims. However, it lacks grounding in cited evidence—no actual studies, papers, or concrete data from PubMed, arXiv, or clinical databases are referenced, despite mentioning them. The plan is plausible and aligned with domain knowledge but is not synthesized from specific retrieved evidence, as no web search or RAG was performed (as noted in the response).",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3643,
            "output_tokens": 129,
            "total_tokens": 3772,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 0.5
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 0.5,\n  \"rationale\": \"The response provides general best-practice guidance for AI in oncology research but does not synthesize or attribute any specific cited evidence. It references common datasets (e.g., TCGA, NLST) and tools (e.g., AlphaFold2) as domain knowledge, but there is no clear attribution to sources, and the plan is not grounded in specific cited material from the provided context (which had no tool runs or citations).\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response provides general best-practice guidance for AI in oncology research but does not synthesize or attribute any specific cited evidence. It references common datasets (e.g., TCGA, NLST) and tools (e.g., AlphaFold2) as domain knowledge, but there is no clear attribution to sources, and the plan is not grounded in specific cited material from the provided context (which had no tool runs or citations).",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3443,
            "output_tokens": 110,
            "total_tokens": 3553,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 0.5
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "```json\n{\n  \"score\": 1.0,\n  \"rationale\": \"The response draws on established domain knowledge and accurately references specific real-world datasets (e.g., TCGA, NLST, UK Biobank) and models (e.g., ViT, AlphaFold2, BioBERT) with clear inline attribution, synthesizing them faithfully into experiment designs without contradictions or fabrications. However, it explicitly notes 'Web search unavailable' and relies on general knowledge rather than retrieved cited evidence, resulting in minor omissions of direct source links or systematic reviews as suggested. This aligns with largely faithful synthesis but not exceptional attribution from RAG.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response draws on established domain knowledge and accurately references specific real-world datasets (e.g., TCGA, NLST, UK Biobank) and models (e.g., ViT, AlphaFold2, BioBERT) with clear inline attribution, synthesizing them faithfully into experiment designs without contradictions or fabrications. However, it explicitly notes 'Web search unavailable' and relies on general knowledge rather than retrieved cited evidence, resulting in minor omissions of direct source links or systematic reviews as suggested. This aligns with largely faithful synthesis but not exceptional attribution from RAG.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3465,
            "output_tokens": 873,
            "total_tokens": 4338,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 735
            }
          },
          "score": 1.0
        }
      ]
    },
    "citation_relevance": {
      "score": 0.0,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.0,\n  \"rationale\": \"The response mentions general sources like PubMed, arXiv, and ClinicalTrials.gov as places to find literature, but does not cite specific papers, studies, or established findings to back up its claims about cancer biology, AI performance benchmarks, or clinical timelines. While the suggested sources are relevant to the domain, the lack of concrete citations means the references are only tangentially related to the specific claims made (e.g., '90% failure rate in oncology trials', 'AUC >0.95 achievable').\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response mentions general sources like PubMed, arXiv, and ClinicalTrials.gov as places to find literature, but does not cite specific papers, studies, or established findings to back up its claims about cancer biology, AI performance benchmarks, or clinical timelines. While the suggested sources are relevant to the domain, the lack of concrete citations means the references are only tangentially related to the specific claims made (e.g., '90% failure rate in oncology trials', 'AUC >0.95 achievable').",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3565,
            "output_tokens": 134,
            "total_tokens": 3699,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 0.0,\n  \"rationale\": \"The response makes numerous specific claims about cancer statistics, clinical timelines, and AI model performance but provides zero citations to support them. For example, it states cancer is the 'second leading cause of death globally (10M deaths/year)' and that '90% failure rate in oncology trials' without any references. The rubric defines a score of 0.0 for irrelevant citations, and here citations are entirely absent, which is functionally equivalent to being irrelevant for supporting the claims.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response makes numerous specific claims about cancer statistics, clinical timelines, and AI model performance but provides zero citations to support them. For example, it states cancer is the 'second leading cause of death globally (10M deaths/year)' and that '90% failure rate in oncology trials' without any references. The rubric defines a score of 0.0 for irrelevant citations, and here citations are entirely absent, which is functionally equivalent to being irrelevant for supporting the claims.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3367,
            "output_tokens": 119,
            "total_tokens": 3486,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 0.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":2.0,\"rationale\":\"The response embeds numerous specific references to datasets (e.g., NLST with 53k patients for lung cancer imaging, TCGA-BRCA for breast cancer genomics), models (e.g., PLCO_m2012 risk model, Google's lung cancer detection), and databases (e.g., ChEMBL for bioactivity data, ClinicalTrials.gov for trial criteria) that directly support claims about experimental setups, data availability, baselines, and expected outcomes, such as achieving AUC >0.95 in diagnostics or generating drug candidates with <10nM affinity. These references are precisely tailored to the oncology AI context, validating the feasibility of multi-modal models, treatment prediction, and drug discovery workflows without any irrelevant mentions. Factual claims like global cancer death rates or trial failure rates (90%) are contextualized by these domain-specific sources, enhancing their evidential support.\",\"confidence\":\"high\"}",
          "rationale": "The response embeds numerous specific references to datasets (e.g., NLST with 53k patients for lung cancer imaging, TCGA-BRCA for breast cancer genomics), models (e.g., PLCO_m2012 risk model, Google's lung cancer detection), and databases (e.g., ChEMBL for bioactivity data, ClinicalTrials.gov for trial criteria) that directly support claims about experimental setups, data availability, baselines, and expected outcomes, such as achieving AUC >0.95 in diagnostics or generating drug candidates with <10nM affinity. These references are precisely tailored to the oncology AI context, validating the feasibility of multi-modal models, treatment prediction, and drug discovery workflows without any irrelevant mentions. Factual claims like global cancer death rates or trial failure rates (90%) are contextualized by these domain-specific sources, enhancing their evidential support.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3391,
            "output_tokens": 778,
            "total_tokens": 4169,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 593
            }
          },
          "score": 2.0
        }
      ]
    },
    "source_fit": {
      "score": 1.1851851851851851,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.0,\n  \"rationale\": \"The response acknowledges the lack of real-time web search and instead relies on established domain knowledge, citing major public datasets (TCGA, NLST, UK Biobank), clinical trial repositories (ClinicalTrials.gov), and standard benchmarks (ChEMBL, PDB). It references realistic timelines and regulatory pathways (FDA Breakthrough Device) and aligns with high-impact venues (Nature Medicine, Lancet Oncology). However, it does not cite specific recent papers (e.g., from 2022–2024) or cutting-edge AI-oncology studies, which would be expected for a 2.0 score. The sources are generally appropriate but not optimally tailored to the user’s (overambitious) goal or expertise level, as no actual literature is cited—only general resources are mentioned.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response acknowledges the lack of real-time web search and instead relies on established domain knowledge, citing major public datasets (TCGA, NLST, UK Biobank), clinical trial repositories (ClinicalTrials.gov), and standard benchmarks (ChEMBL, PDB). It references realistic timelines and regulatory pathways (FDA Breakthrough Device) and aligns with high-impact venues (Nature Medicine, Lancet Oncology). However, it does not cite specific recent papers (e.g., from 2022–2024) or cutting-edge AI-oncology studies, which would be expected for a 2.0 score. The sources are generally appropriate but not optimally tailored to the user’s (overambitious) goal or expertise level, as no actual literature is cited—only general resources are mentioned.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3581,
            "output_tokens": 195,
            "total_tokens": 3776,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1.0,\n  \"rationale\": \"The response cites generally appropriate and relevant sources, such as PubMed, arXiv, ClinicalTrials.gov, and specific datasets (e.g., NLST, TCGA, UK Biobank, GENIE, ChEMBL) that are standard for the field. However, the rubric for a 2.0 score requires the sources to be appropriate for the user's goal *and expertise*, and there is no consideration of the user's likely expertise level (which is unknown) or clear guidance on how to access these sources for the stated 'impossible timeline.' The mention is acceptable but broad and not tailored.\",\n  \"confidence\": \"medium\"\n}",
          "rationale": "The response cites generally appropriate and relevant sources, such as PubMed, arXiv, ClinicalTrials.gov, and specific datasets (e.g., NLST, TCGA, UK Biobank, GENIE, ChEMBL) that are standard for the field. However, the rubric for a 2.0 score requires the sources to be appropriate for the user's goal *and expertise*, and there is no consideration of the user's likely expertise level (which is unknown) or clear guidance on how to access these sources for the stated 'impossible timeline.' The mention is acceptable but broad and not tailored.",
          "confidence": "medium",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3385,
            "output_tokens": 146,
            "total_tokens": 3531,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1.5,\"rationale\":\"The response cites highly relevant sources like TCGA, NLST, GENIE, ChEMBL, and PDB, which are foundational and appropriate for AI-oncology research planning, with venues such as Nature Medicine and tools like AlphaFold2 (2021) ensuring good recency for key elements. However, reliance on established datasets (e.g., TCGA from 2010s) without live recent searches (noted as 'Web search unavailable') makes it solid but slightly suboptimal for the most current advancements in a fast-evolving field like AI in cancer. This fits a general researcher's expertise well for experiment design but doesn't push exceptional boundaries.\",\"confidence\":\"high\"}",
          "rationale": "The response cites highly relevant sources like TCGA, NLST, GENIE, ChEMBL, and PDB, which are foundational and appropriate for AI-oncology research planning, with venues such as Nature Medicine and tools like AlphaFold2 (2021) ensuring good recency for key elements. However, reliance on established datasets (e.g., TCGA from 2010s) without live recent searches (noted as 'Web search unavailable') makes it solid but slightly suboptimal for the most current advancements in a fast-evolving field like AI in cancer. This fits a general researcher's expertise well for experiment design but doesn't push exceptional boundaries.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3405,
            "output_tokens": 753,
            "total_tokens": 4158,
            "input_token_details": {
              "audio": 0,
              "cache_read": 250
            },
            "output_token_details": {
              "reasoning": 611
            }
          },
          "score": 1.5
        }
      ]
    },
    "citation_quality": {
      "score": 0.0,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.0,\n  \"rationale\": \"The response cites real and relevant datasets (e.g., TCGA, NLST, UK Biobank, ChEMBL, PDB) and clinical trial repositories (ClinicalTrials.gov), which are authoritative in biomedical research. However, it does not include formal scholarly citations (e.g., author, journal, year, DOI) or reference specific peer-reviewed studies to support claims about AI performance, clinical benchmarks, or timelines. Instead, it mentions general resources and tools (e.g., 'Google's lung cancer detection model', 'Foundation Medicine CDx') without full citations. While the references are real and partially aligned with the claims, they lack the scholarly formatting and direct linkage required for a 2.0.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response cites real and relevant datasets (e.g., TCGA, NLST, UK Biobank, ChEMBL, PDB) and clinical trial repositories (ClinicalTrials.gov), which are authoritative in biomedical research. However, it does not include formal scholarly citations (e.g., author, journal, year, DOI) or reference specific peer-reviewed studies to support claims about AI performance, clinical benchmarks, or timelines. Instead, it mentions general resources and tools (e.g., 'Google's lung cancer detection model', 'Foundation Medicine CDx') without full citations. While the references are real and partially aligned with the claims, they lack the scholarly formatting and direct linkage required for a 2.0.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3633,
            "output_tokens": 173,
            "total_tokens": 3806,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 0.0,\n  \"rationale\": \"The response contains no citations. It references datasets (e.g., NLST, TCGA, UK Biobank) and tools (e.g., AlphaFold2, BioBERT) by name, but these are not formatted as citations and no supporting references are provided. The rubric specifies a score of 0.0 for missing citations.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response contains no citations. It references datasets (e.g., NLST, TCGA, UK Biobank) and tools (e.g., AlphaFold2, BioBERT) by name, but these are not formatted as citations and no supporting references are provided. The rubric specifies a score of 0.0 for missing citations.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3441,
            "output_tokens": 93,
            "total_tokens": 3534,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 0.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":0.0,\"rationale\":\"The response lacks formal citations, with no in-text references, footnotes, or bibliography to support key claims such as cancer statistics (e.g., '10M deaths/year', '50-70% of cancers detected at advanced stages') or expected outcomes. While it mentions real, authoritative resources like TCGA, NLST, PubMed, arXiv, and ClinicalTrials.gov inline to describe data sources and methods, these are not formatted as citations and do not directly reference supporting evidence for broader assertions. This results in missing or absent citations overall.\",\"confidence\":\"high\"}",
          "rationale": "The response lacks formal citations, with no in-text references, footnotes, or bibliography to support key claims such as cancer statistics (e.g., '10M deaths/year', '50-70% of cancers detected at advanced stages') or expected outcomes. While it mentions real, authoritative resources like TCGA, NLST, PubMed, arXiv, and ClinicalTrials.gov inline to describe data sources and methods, these are not formatted as citations and do not directly reference supporting evidence for broader assertions. This results in missing or absent citations overall.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3459,
            "output_tokens": 1012,
            "total_tokens": 4471,
            "input_token_details": {
              "audio": 0,
              "cache_read": 201
            },
            "output_token_details": {
              "reasoning": 890
            }
          },
          "score": 0.0
        }
      ]
    },
    "clarification_quality": {
      "score": 1.3333333333333333,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.5,\n  \"rationale\": \"The agent explicitly reframes the user's unrealistic goal ('cure cancer with AI tomorrow') into a scientifically grounded, staged research plan, stating clear assumptions about cancer's complexity, clinical timelines, and AI's current capabilities. It identifies key bottlenecks (late diagnosis, treatment selection, etc.) and sets measurable 6-month objectives. However, it does not ask any clarifying questions about the user's background, resources, or specific cancer type of interest, which could have tailored the plan more effectively (e.g., focusing on a particular modality or institution). While assumptions are well-stated and materially improve guidance, the lack of targeted probes prevents a 2.0 score.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent explicitly reframes the user's unrealistic goal ('cure cancer with AI tomorrow') into a scientifically grounded, staged research plan, stating clear assumptions about cancer's complexity, clinical timelines, and AI's current capabilities. It identifies key bottlenecks (late diagnosis, treatment selection, etc.) and sets measurable 6-month objectives. However, it does not ask any clarifying questions about the user's background, resources, or specific cancer type of interest, which could have tailored the plan more effectively (e.g., focusing on a particular modality or institution). While assumptions are well-stated and materially improve guidance, the lack of targeted probes prevents a 2.0 score.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3672,
            "output_tokens": 165,
            "total_tokens": 3837,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.5
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1.0,\n  \"rationale\": \"The response states a critical, explicit assumption that reframes the unrealistic timeline to a realistic one, which is essential for providing sound guidance. However, it provides no targeted clarifying questions to understand the researcher's specific resources, expertise, or cancer focus, which would materially improve the quality and specificity of the experimental plans.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response states a critical, explicit assumption that reframes the unrealistic timeline to a realistic one, which is essential for providing sound guidance. However, it provides no targeted clarifying questions to understand the researcher's specific resources, expertise, or cancer focus, which would materially improve the quality and specificity of the experimental plans.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3476,
            "output_tokens": 87,
            "total_tokens": 3563,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1.5,\"rationale\":\"The response states explicit assumptions by reframing the impossible 'cure cancer tomorrow' goal into a realistic 6-month plan targeting near-term AI impacts like early detection and treatment prediction, which materially improves guidance quality by providing feasible, structured experiments. It draws on established domain knowledge and suggests literature reviews for rigor, but lacks targeted clarifying questions about the user's background, expertise, or specific cancer interests, resulting in minor gaps in tailoring the plan.\",\"confidence\":\"high\"}",
          "rationale": "The response states explicit assumptions by reframing the impossible 'cure cancer tomorrow' goal into a realistic 6-month plan targeting near-term AI impacts like early detection and treatment prediction, which materially improves guidance quality by providing feasible, structured experiments. It draws on established domain knowledge and suggests literature reviews for rigor, but lacks targeted clarifying questions about the user's background, expertise, or specific cancer interests, resulting in minor gaps in tailoring the plan.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3498,
            "output_tokens": 817,
            "total_tokens": 4315,
            "input_token_details": {
              "audio": 0,
              "cache_read": 250
            },
            "output_token_details": {
              "reasoning": 716
            }
          },
          "score": 1.5
        }
      ]
    },
    "actionability": {
      "score": 1.6666666666666667,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.5,\n  \"rationale\": \"The response provides a highly structured, detailed 6-month research plan with four well-defined experiments, each specifying hypotheses, architectures, data sources, baselines, evaluation metrics, expected outcomes, and ablations. However, it lacks concrete executable commands (e.g., code snippets, software tool calls, API endpoints) or precise parameter settings (e.g., learning rates, model sizes, batch sizes) that would allow immediate implementation. While the steps are clear and technically grounded, a user would still need to design specific pipelines, select software libraries, and configure training environments—minor but notable gaps for full actionability.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response provides a highly structured, detailed 6-month research plan with four well-defined experiments, each specifying hypotheses, architectures, data sources, baselines, evaluation metrics, expected outcomes, and ablations. However, it lacks concrete executable commands (e.g., code snippets, software tool calls, API endpoints) or precise parameter settings (e.g., learning rates, model sizes, batch sizes) that would allow immediate implementation. While the steps are clear and technically grounded, a user would still need to design specific pipelines, select software libraries, and configure training environments—minor but notable gaps for full actionability.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3631,
            "output_tokens": 150,
            "total_tokens": 3781,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.5
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1.5,\n  \"rationale\": \"The response provides clear, structured next steps with specific experiments, architectures, datasets, and evaluation metrics, but lacks concrete executable commands, parameters, or immediate, granular actions a user could take 'tomorrow' to begin implementation. The guidance is highly detailed and actionable in a research planning sense, but the user must still fill gaps in operationalizing the first steps (e.g., specific code, exact commands to access datasets, parameter settings for initial model training).\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response provides clear, structured next steps with specific experiments, architectures, datasets, and evaluation metrics, but lacks concrete executable commands, parameters, or immediate, granular actions a user could take 'tomorrow' to begin implementation. The guidance is highly detailed and actionable in a research planning sense, but the user must still fill gaps in operationalizing the first steps (e.g., specific code, exact commands to access datasets, parameter settings for initial model training).",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3435,
            "output_tokens": 117,
            "total_tokens": 3552,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.5
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":2.0,\"rationale\":\"The response provides concrete executable steps across experiments, such as using Vision Transformer (ViT) pretrained on ImageNet and fine-tuned on NLST/TCGA-BRCA datasets for Experiment 1, with specific parameters like AUC >0.95 and expected outcomes like 15-20% more stage I detections; Experiment 3 details a workflow with tools like AlphaFold2 for structure preparation, generating 10k-100k candidates, docking via AutoDock Vina, and MD simulations with GROMACS for 100ns, targeting binding affinity <10nM. These include commands/tools, hyperparameters, and measurable outcomes, making the plan highly actionable for a researcher despite the impossible timeline constraint.\",\"confidence\":\"high\"}",
          "rationale": "The response provides concrete executable steps across experiments, such as using Vision Transformer (ViT) pretrained on ImageNet and fine-tuned on NLST/TCGA-BRCA datasets for Experiment 1, with specific parameters like AUC >0.95 and expected outcomes like 15-20% more stage I detections; Experiment 3 details a workflow with tools like AlphaFold2 for structure preparation, generating 10k-100k candidates, docking via AutoDock Vina, and MD simulations with GROMACS for 100ns, targeting binding affinity <10nM. These include commands/tools, hyperparameters, and measurable outcomes, making the plan highly actionable for a researcher despite the impossible timeline constraint.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3457,
            "output_tokens": 581,
            "total_tokens": 4038,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 428
            }
          },
          "score": 2.0
        }
      ]
    },
    "persona_compliance": {
      "score": 1.8333333333333333,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.5,\n  \"rationale\": \"The response adopts a guiding, mentor-like tone by gently correcting the user's unrealistic timeline ('not scientifically feasible') and reframing the goal into actionable, staged objectives. It provides structured, detailed guidance across multiple experiments with clear hypotheses, methods, and metrics—demonstrating active mentorship. However, it lacks explicit encouragement or motivational language (e.g., 'This is ambitious but your focus on AI is well-placed' or 'Many researchers start with similar goals—here’s how to channel that energy'). The tone is professional and supportive through substance, but not overtly nurturing or emotionally encouraging.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response adopts a guiding, mentor-like tone by gently correcting the user's unrealistic timeline ('not scientifically feasible') and reframing the goal into actionable, staged objectives. It provides structured, detailed guidance across multiple experiments with clear hypotheses, methods, and metrics—demonstrating active mentorship. However, it lacks explicit encouragement or motivational language (e.g., 'This is ambitious but your focus on AI is well-placed' or 'Many researchers start with similar goals—here’s how to channel that energy'). The tone is professional and supportive through substance, but not overtly nurturing or emotionally encouraging.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3577,
            "output_tokens": 149,
            "total_tokens": 3726,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.5
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response consistently adopts an encouraging and guiding mentor persona, beginning with a critical but constructive reality check that reframes the user's goal into a realistic, structured plan. It maintains a supportive tone throughout by providing detailed, actionable experiments and goals, using phrases like \\\"This plan reframes the goal to maximize AI's impact\\\" and offering clear, step-by-step guidance for demonstrable progress.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response consistently adopts an encouraging and guiding mentor persona, beginning with a critical but constructive reality check that reframes the user's goal into a realistic, structured plan. It maintains a supportive tone throughout by providing detailed, actionable experiments and goals, using phrases like \"This plan reframes the goal to maximize AI's impact\" and offering clear, step-by-step guidance for demonstrable progress.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3382,
            "output_tokens": 103,
            "total_tokens": 3485,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":2.0,\"rationale\":\"The response embodies a consistently encouraging and guiding mentor persona by acknowledging the user's ambitious goal with a 'Critical Reality Check' while reframing it into realistic, high-impact objectives, such as improving diagnosis and treatment within 6-12 months. It provides detailed, structured guidance through sections like 'Problem Framing and Goals' and specific experiments (e.g., Experiment 1 on multi-modal AI for early detection, including hypotheses, setups, baselines, and expected outcomes), fostering progress without discouragement. Secondary goals like establishing partnerships, publishing papers, and open-sourcing tools further demonstrate supportive mentorship.\",\"confidence\":\"high\"}",
          "rationale": "The response embodies a consistently encouraging and guiding mentor persona by acknowledging the user's ambitious goal with a 'Critical Reality Check' while reframing it into realistic, high-impact objectives, such as improving diagnosis and treatment within 6-12 months. It provides detailed, structured guidance through sections like 'Problem Framing and Goals' and specific experiments (e.g., Experiment 1 on multi-modal AI for early detection, including hypotheses, setups, baselines, and expected outcomes), fostering progress without discouragement. Secondary goals like establishing partnerships, publishing papers, and open-sourcing tools further demonstrate supportive mentorship.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3403,
            "output_tokens": 407,
            "total_tokens": 3810,
            "input_token_details": {
              "audio": 0,
              "cache_read": 250
            },
            "output_token_details": {
              "reasoning": 277
            }
          },
          "score": 2.0
        }
      ]
    },
    "stage_awareness": {
      "score": 1.6666666666666667,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.0,\n  \"rationale\": \"The user expresses an unrealistic goal ('cure cancer with AI tomorrow'), which suggests they are in the early orientation or hypothesis stage (Stage A or B), not Stage C (Research Planning). The agent correctly identifies the infeasibility and reframes the goal, but then immediately dives into a highly detailed 6-month research plan with four complex experiments—appropriate for Stage C or beyond. This jumps ahead of the user’s likely stage, as foundational work (literature review, problem scoping, feasibility assessment) should precede experimental design. While the response is technically impressive, it misjudges the user’s readiness for detailed planning.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The user expresses an unrealistic goal ('cure cancer with AI tomorrow'), which suggests they are in the early orientation or hypothesis stage (Stage A or B), not Stage C (Research Planning). The agent correctly identifies the infeasibility and reframes the goal, but then immediately dives into a highly detailed 6-month research plan with four complex experiments—appropriate for Stage C or beyond. This jumps ahead of the user’s likely stage, as foundational work (literature review, problem scoping, feasibility assessment) should precede experimental design. While the response is technically impressive, it misjudges the user’s readiness for detailed planning.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3595,
            "output_tokens": 155,
            "total_tokens": 3750,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response demonstrates exceptional stage awareness by explicitly reframing the user's unrealistic goal into a structured, multi-phase research plan focused on designing experiments and creating a 6-month plan. It directly addresses the 'Research Planning' stage (C) by outlining specific experiments with hypotheses, setups, baselines, and evaluation metrics, rather than jumping ahead to methodology or implementation details.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response demonstrates exceptional stage awareness by explicitly reframing the user's unrealistic goal into a structured, multi-phase research plan focused on designing experiments and creating a 6-month plan. It directly addresses the 'Research Planning' stage (C) by outlining specific experiments with hypotheses, setups, baselines, and evaluation metrics, rather than jumping ahead to methodology or implementation details.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3401,
            "output_tokens": 99,
            "total_tokens": 3500,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":2.0,\"rationale\":\"The response clearly recognizes the user's request for a research plan in the context of an unrealistic timeline, reframing it into a structured 6-month plan focused on Stage C: Research Planning, including problem framing, goals, and detailed experiment designs with hypotheses, setups, baselines, and evaluations. It tailors guidance specifically to designing experiments for AI in cancer without advancing to implementation or other stages, such as by emphasizing near-term tractable problems and data partnerships. This exceptional alignment sets a high bar for stage awareness.\",\"confidence\":\"high\"}",
          "rationale": "The response clearly recognizes the user's request for a research plan in the context of an unrealistic timeline, reframing it into a structured 6-month plan focused on Stage C: Research Planning, including problem framing, goals, and detailed experiment designs with hypotheses, setups, baselines, and evaluations. It tailors guidance specifically to designing experiments for AI in cancer without advancing to implementation or other stages, such as by emphasizing near-term tractable problems and data partnerships. This exceptional alignment sets a high bar for stage awareness.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3419,
            "output_tokens": 420,
            "total_tokens": 3839,
            "input_token_details": {
              "audio": 0,
              "cache_read": 250
            },
            "output_token_details": {
              "reasoning": 305
            }
          },
          "score": 2.0
        }
      ]
    },
    "tone_constructive": {
      "score": 1.5,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1.5,\n  \"rationale\": \"The response begins with a necessary 'Critical Reality Check' that directly addresses the user's unrealistic timeline, which could risk sounding discouraging. However, it quickly pivots to a highly constructive, detailed, and motivating plan that reframes the goal into actionable, time-bound research objectives. It reinforces progress by outlining concrete experiments, measurable outcomes, and realistic milestones, all while maintaining scientific rigor. The tone is professional and encouraging without resorting to empty praise or fluff, though the initial bluntness slightly tempers the overall motivational impact.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response begins with a necessary 'Critical Reality Check' that directly addresses the user's unrealistic timeline, which could risk sounding discouraging. However, it quickly pivots to a highly constructive, detailed, and motivating plan that reframes the goal into actionable, time-bound research objectives. It reinforces progress by outlining concrete experiments, measurable outcomes, and realistic milestones, all while maintaining scientific rigor. The tone is professional and encouraging without resorting to empty praise or fluff, though the initial bluntness slightly tempers the overall motivational impact.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3601,
            "output_tokens": 136,
            "total_tokens": 3737,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.5
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1.0,\n  \"rationale\": \"The response maintains a neutral to mildly encouraging tone by reframing the user's impossible goal into a structured, realistic plan, using phrases like 'reframes the goal to maximize AI's impact' and 'targets demonstrable progress'. However, it lacks the explicitly constructive and motivating language that would reinforce progress and earn a higher score, as it is primarily focused on providing a detailed, factual plan rather than on encouragement.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response maintains a neutral to mildly encouraging tone by reframing the user's impossible goal into a structured, realistic plan, using phrases like 'reframes the goal to maximize AI's impact' and 'targets demonstrable progress'. However, it lacks the explicitly constructive and motivating language that would reinforce progress and earn a higher score, as it is primarily focused on providing a detailed, factual plan rather than on encouragement.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3408,
            "output_tokens": 109,
            "total_tokens": 3517,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":2.0,\"rationale\":\"The response begins with a candid 'Critical Reality Check' acknowledging the infeasibility of curing cancer tomorrow but swiftly reframes it into realistic, high-impact goals like improving diagnosis and treatment within 6-12 months, motivating the user by emphasizing 'demonstrable progress' on tractable problems. It reinforces progress through specific, ambitious yet achievable primary and secondary goals, such as deploying AI models with AUC >0.95 and publishing in high-impact journals, without fluff by grounding everything in detailed experiments, hypotheses, and metrics. This constructive pivot encourages forward momentum while maintaining scientific rigor.\",\"confidence\":\"high\"}",
          "rationale": "The response begins with a candid 'Critical Reality Check' acknowledging the infeasibility of curing cancer tomorrow but swiftly reframes it into realistic, high-impact goals like improving diagnosis and treatment within 6-12 months, motivating the user by emphasizing 'demonstrable progress' on tractable problems. It reinforces progress through specific, ambitious yet achievable primary and secondary goals, such as deploying AI models with AUC >0.95 and publishing in high-impact journals, without fluff by grounding everything in detailed experiments, hypotheses, and metrics. This constructive pivot encourages forward momentum while maintaining scientific rigor.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3419,
            "output_tokens": 390,
            "total_tokens": 3809,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 261
            }
          },
          "score": 2.0
        }
      ]
    },
    "expectation_management": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly states that 'curing cancer with AI tomorrow is not scientifically feasible' and provides a detailed reality check grounded in scientific and clinical timelines. It reframes the infeasible goal into a structured, multi-phase plan with realistic near-term, medium-term, and long-term objectives aligned with current AI capabilities in oncology. The 6-month plan focuses on tractable, high-impact problems like early detection, treatment matching, and drug discovery acceleration, with measurable outcomes and acknowledgment of clinical validation requirements.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response explicitly states that 'curing cancer with AI tomorrow is not scientifically feasible' and provides a detailed reality check grounded in scientific and clinical timelines. It reframes the infeasible goal into a structured, multi-phase plan with realistic near-term, medium-term, and long-term objectives aligned with current AI capabilities in oncology. The 6-month plan focuses on tractable, high-impact problems like early detection, treatment matching, and drug discovery acceleration, with measurable outcomes and acknowledgment of clinical validation requirements.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3546,
            "output_tokens": 128,
            "total_tokens": 3674,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response begins with a critical reality check stating 'Curing cancer with AI tomorrow' is not scientifically feasible and reframes the goal to maximizing AI's impact within realistic constraints, outlining a phased plan with specific, measurable objectives across near-term (6-12 months), medium-term (2-5 years), and long-term (5-15 years) timelines.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response begins with a critical reality check stating 'Curing cancer with AI tomorrow' is not scientifically feasible and reframes the goal to maximizing AI's impact within realistic constraints, outlining a phased plan with specific, measurable objectives across near-term (6-12 months), medium-term (2-5 years), and long-term (5-15 years) timelines.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3352,
            "output_tokens": 580,
            "total_tokens": 3932,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 486
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The response explicitly addresses the infeasible goal by stating 'Curing cancer with AI tomorrow is not scientifically feasible' and explains the realistic timelines of 5-15 years for clinical translation. It reframes the objective to 'maximize AI's impact on cancer outcomes within realistic constraints,' focusing on a 6-month plan for demonstrable progress in areas like early detection and treatment optimization. This sets clear, achievable expectations while maintaining ambition through specific, measurable goals.\",\"confidence\":\"high\"}",
          "rationale": "The response explicitly addresses the infeasible goal by stating 'Curing cancer with AI tomorrow is not scientifically feasible' and explains the realistic timelines of 5-15 years for clinical translation. It reframes the objective to 'maximize AI's impact on cancer outcomes within realistic constraints,' focusing on a 6-month plan for demonstrable progress in areas like early detection and treatment optimization. This sets clear, achievable expectations while maintaining ambition through specific, measurable goals.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3372,
            "output_tokens": 298,
            "total_tokens": 3670,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 195
            }
          },
          "score": 1.0
        }
      ]
    },
    "plan_completeness": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The response includes clear hypotheses for each of the four experiments (e.g., 'Integrating imaging, genomics, and clinical data via multi-modal transformers can detect cancers 6-12 months earlier...'). Methodology is detailed with architectures, data sources, and training approaches. Evaluation metrics are explicitly defined for each experiment (e.g., AUC, sensitivity, C-index, binding affinity). Required resources are specified (e.g., NLST, TCGA, ChEMBL, partner hospitals, computational tools). Milestones are outlined with 6-month primary goals and expected outcomes tied to timelines. All five required elements—hypotheses, methodology, evaluation, resources, and milestones—are present.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response includes clear hypotheses for each of the four experiments (e.g., 'Integrating imaging, genomics, and clinical data via multi-modal transformers can detect cancers 6-12 months earlier...'). Methodology is detailed with architectures, data sources, and training approaches. Evaluation metrics are explicitly defined for each experiment (e.g., AUC, sensitivity, C-index, binding affinity). Required resources are specified (e.g., NLST, TCGA, ChEMBL, partner hospitals, computational tools). Milestones are outlined with 6-month primary goals and expected outcomes tied to timelines. All five required elements—hypotheses, methodology, evaluation, resources, and milestones—are present.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3551,
            "output_tokens": 168,
            "total_tokens": 3719,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly includes all required components: hypotheses (e.g., \\\"Hypothesis: Integrating imaging... can detect cancers 6-12 months earlier\\\"), methodology (detailed experimental setups, architectures, and workflows), evaluation (specific metrics like AUC, sensitivity, binding affinity), resources (datasets like TCGA, NLST, and computational tools like AlphaFold2), and milestones (near-term 6-12 months, medium-term 2-5 years, and long-term 5-15 years goals).\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly includes all required components: hypotheses (e.g., \"Hypothesis: Integrating imaging... can detect cancers 6-12 months earlier\"), methodology (detailed experimental setups, architectures, and workflows), evaluation (specific metrics like AUC, sensitivity, binding affinity), resources (datasets like TCGA, NLST, and computational tools like AlphaFold2), and milestones (near-term 6-12 months, medium-term 2-5 years, and long-term 5-15 years goals).",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3355,
            "output_tokens": 126,
            "total_tokens": 3481,
            "input_token_details": {
              "audio": 0,
              "cache_read": 64
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The response includes hypotheses for each of the four experiments, such as 'Integrating imaging... can detect cancers 6-12 months earlier' in Experiment 1. Methodologies are detailed in setups, including architectures, data sources, and workflows, e.g., multi-modal transformers and training procedures. Evaluations feature specific metrics like AUC and C-index, with baselines; resources cover datasets (TCGA, NLST), tools (AlphaFold2, BioBERT), and partnerships; milestones are outlined in the 6-month primary goals, expected outcomes per experiment, and secondary goals like publishing 2-3 papers.\",\"confidence\":\"high\"}",
          "rationale": "The response includes hypotheses for each of the four experiments, such as 'Integrating imaging... can detect cancers 6-12 months earlier' in Experiment 1. Methodologies are detailed in setups, including architectures, data sources, and workflows, e.g., multi-modal transformers and training procedures. Evaluations feature specific metrics like AUC and C-index, with baselines; resources cover datasets (TCGA, NLST), tools (AlphaFold2, BioBERT), and partnerships; milestones are outlined in the 6-month primary goals, expected outcomes per experiment, and secondary goals like publishing 2-3 papers.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3379,
            "output_tokens": 696,
            "total_tokens": 4075,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 563
            }
          },
          "score": 1.0
        }
      ]
    },
    "risk_mitigation": {
      "score": 0.0,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly identifies major scientific and practical risks (e.g., 'curing cancer tomorrow is not feasible,' high clinical trial failure rates, data heterogeneity, equity concerns) and pairs each with concrete mitigation strategies. For example, it reframes the unrealistic goal into phased, tractable objectives; proposes multi-modal validation to reduce false positives; includes ablation studies to assess model robustness; and emphasizes prospective validation, regulatory pathways, and equity evaluations to address real-world deployment risks.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response explicitly identifies major scientific and practical risks (e.g., 'curing cancer tomorrow is not feasible,' high clinical trial failure rates, data heterogeneity, equity concerns) and pairs each with concrete mitigation strategies. For example, it reframes the unrealistic goal into phased, tractable objectives; proposes multi-modal validation to reduce false positives; includes ablation studies to assess model robustness; and emphasizes prospective validation, regulatory pathways, and equity evaluations to address real-world deployment risks.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3537,
            "output_tokens": 122,
            "total_tokens": 3659,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 0,\n  \"rationale\": \"The agent's response provides a detailed research plan but does not explicitly pair risks with mitigation strategies. For instance, while it acknowledges overarching challenges like late diagnosis and drug development failures in the 'Critical Reality Check' and problem statement, it lacks specific identification of experimental risks (e.g., data quality issues, model overfitting) paired with corresponding mitigations (e.g., data validation protocols, regularization techniques) in the experiment sections.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The agent's response provides a detailed research plan but does not explicitly pair risks with mitigation strategies. For instance, while it acknowledges overarching challenges like late diagnosis and drug development failures in the 'Critical Reality Check' and problem statement, it lacks specific identification of experimental risks (e.g., data quality issues, model overfitting) paired with corresponding mitigations (e.g., data validation protocols, regularization techniques) in the experiment sections.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3341,
            "output_tokens": 1215,
            "total_tokens": 4556,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 1108
            }
          },
          "score": 0.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":0,\"rationale\":\"The response provides a comprehensive research plan with built-in validation steps, baselines, ablations, and realistic goal reframing, but it does not explicitly identify specific risks (such as data privacy concerns, model overfitting, ethical issues in clinical trials, or high failure rates in drug discovery) and pair them directly with targeted mitigation strategies. Instead, safeguards like prospective validation, equity evaluations, and stepwise filtering are embedded in the experimental designs without framing them as responses to named risks. This lacks the explicit pairing required by the metric.\",\"confidence\":\"high\"}",
          "rationale": "The response provides a comprehensive research plan with built-in validation steps, baselines, ablations, and realistic goal reframing, but it does not explicitly identify specific risks (such as data privacy concerns, model overfitting, ethical issues in clinical trials, or high failure rates in drug discovery) and pair them directly with targeted mitigation strategies. Instead, safeguards like prospective validation, equity evaluations, and stepwise filtering are embedded in the experimental designs without framing them as responses to named risks. This lacks the explicit pairing required by the metric.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3365,
            "output_tokens": 622,
            "total_tokens": 3987,
            "input_token_details": {
              "audio": 0,
              "cache_read": 151
            },
            "output_token_details": {
              "reasoning": 507
            }
          },
          "score": 0.0
        }
      ]
    },
    "feasibility_analysis": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly evaluates feasibility across all three required dimensions: (1) Skills – references established AI/ML techniques (transformers, GNNs, diffusion models) and assumes access to expertise in oncology, bioinformatics, and clinical validation; (2) Data – specifies concrete, real-world datasets (NLST, TCGA, GENIE, EMBED, ChEMBL, PDB, ClinicalTrials.gov, EHRs) and acknowledges data partnership needs; (3) Compute – implies substantial computational resources through mentions of large-scale training (multi-modal models, generative AI, molecular dynamics simulations) and in silico screening of 10k–100k candidates, which require significant GPU/TPU infrastructure. The plan is grounded in realistic resource assumptions despite the user's unrealistic timeline.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response explicitly evaluates feasibility across all three required dimensions: (1) Skills – references established AI/ML techniques (transformers, GNNs, diffusion models) and assumes access to expertise in oncology, bioinformatics, and clinical validation; (2) Data – specifies concrete, real-world datasets (NLST, TCGA, GENIE, EMBED, ChEMBL, PDB, ClinicalTrials.gov, EHRs) and acknowledges data partnership needs; (3) Compute – implies substantial computational resources through mentions of large-scale training (multi-modal models, generative AI, molecular dynamics simulations) and in silico screening of 10k–100k candidates, which require significant GPU/TPU infrastructure. The plan is grounded in realistic resource assumptions despite the user's unrealistic timeline.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3542,
            "output_tokens": 191,
            "total_tokens": 3733,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly evaluates feasibility across skills, data, and compute for each proposed experiment. For example, in Experiment 1, it details required data sources (NLST, TCGA), model architectures (ViT, CNN), and computational training approaches. In Experiment 3, it specifies generative models (diffusion models), data (ChEMBL, PDB), and in silico workflows requiring significant compute.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly evaluates feasibility across skills, data, and compute for each proposed experiment. For example, in Experiment 1, it details required data sources (NLST, TCGA), model architectures (ViT, CNN), and computational training approaches. In Experiment 3, it specifies generative models (diffusion models), data (ChEMBL, PDB), and in silico workflows requiring significant compute.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3349,
            "output_tokens": 105,
            "total_tokens": 3454,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":0,\"rationale\":\"The response evaluates data feasibility by detailing specific datasets (e.g., NLST, TCGA, ChEMBL) and the need for partnerships, but it does not assess required skills (e.g., expertise in AI, oncology, or team composition) or compute resources (e.g., GPU needs for training models or simulations). While it reframes the impossible timeline into realistic phases, the feasibility analysis is incomplete across the specified dimensions.\",\"confidence\":\"high\"}",
          "rationale": "The response evaluates data feasibility by detailing specific datasets (e.g., NLST, TCGA, ChEMBL) and the need for partnerships, but it does not assess required skills (e.g., expertise in AI, oncology, or team composition) or compute resources (e.g., GPU needs for training models or simulations). While it reframes the impossible timeline into realistic phases, the feasibility analysis is incomplete across the specified dimensions.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 3370,
            "output_tokens": 470,
            "total_tokens": 3840,
            "input_token_details": {
              "audio": 0,
              "cache_read": 250
            },
            "output_token_details": {
              "reasoning": 372
            }
          },
          "score": 0.0
        }
      ]
    },
    "holistic_score": {
      "score": 1.5,
      "judges": [
        {
          "judge": "openrouter:qwen/qwen3-max",
          "raw": "```json\n{\n  \"weaknesses_identified\": [\n    \"The response assumes access to extensive resources (e.g., partnerships with 2-3 cancer centers, proprietary hospital data, wet-lab validation capabilities, and regulatory pathways) that are unrealistic for an individual researcher or small team, especially without clarifying the user’s background, funding, or institutional support.\",\n    \"While the plan reframes the user’s overly ambitious goal appropriately, it does not guide the user on how to start small or prioritize one experiment based on their actual constraints (e.g., compute, data access, expertise). Instead, it presents four parallel, resource-intensive projects as if they are all feasible within 6 months for a single actor.\"\n  ],\n  \"score\": 1.5,\n  \"rationale\": \"The response excels in scientific realism, structure, and domain knowledge, offering detailed, actionable experiments with specific datasets, architectures, and metrics. However, it fails to calibrate advice to the likely constraints of a typical user (e.g., a grad student or independent researcher) by assuming access to clinical data, hospital partnerships, and drug synthesis infrastructure. This reduces its practical actionability for most users despite its technical rigor.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response excels in scientific realism, structure, and domain knowledge, offering detailed, actionable experiments with specific datasets, architectures, and metrics. However, it fails to calibrate advice to the likely constraints of a typical user (e.g., a grad student or independent researcher) by assuming access to clinical data, hospital partnerships, and drug synthesis infrastructure. This reduces its practical actionability for most users despite its technical rigor.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 7192,
            "output_tokens": 256,
            "total_tokens": 7448,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.5
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"weaknesses_identified\": [\n    \"The response is overwhelmingly detailed and complex, likely overwhelming for a user with an unknown background who asked a naive, ambitious question. It lacks a clear, prioritized first step for the user to take, assuming they have the resources and expertise to execute a multi-project research plan.\",\n    \"It fails to ask any clarifying questions about the user's background, resources, or specific interests, which is critical given the ambiguous persona and the unrealistic initial query. The response dives directly into a technical plan without establishing a shared understanding of feasibility.\"\n  ],\n  \"score\": 1.25,\n  \"rationale\": \"The response provides a technically comprehensive and well-structured research plan that expertly reframes an impossible goal into tractable projects, demonstrating strong domain knowledge. However, it is poorly calibrated to the user's likely novice persona and the mentoring context; it is more of a detailed research proposal than a guiding, actionable first conversation. The lack of clarification and the overwhelming detail are significant weaknesses in the holistic user experience.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response provides a technically comprehensive and well-structured research plan that expertly reframes an impossible goal into tractable projects, demonstrating strong domain knowledge. However, it is poorly calibrated to the user's likely novice persona and the mentoring context; it is more of a detailed research proposal than a guiding, actionable first conversation. The lack of clarification and the overwhelming detail are significant weaknesses in the holistic user experience.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6817,
            "output_tokens": 221,
            "total_tokens": 7038,
            "input_token_details": {
              "audio": 0,
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.25
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 1.75, \"rationale\": \"The response excels in providing a detailed, actionable research plan tailored to the unrealistic query by reframing it into feasible 6-month goals with specific experiments, datasets, architectures, and metrics, aligning well with Stage C research planning and acting as a supportive mentor. However, it has minor flaws including truncation in Experiment 4, which leaves the plan incomplete, and assumptions about access to advanced resources like hospital partnerships and in vitro validation without addressing the user's unknown expertise or providing scaled-down alternatives. Overall, it equips the user with clear direction and expert guidance, with only slight uncertainties in feasibility.\", \"confidence\": \"high\"}",
          "rationale": "The response excels in providing a detailed, actionable research plan tailored to the unrealistic query by reframing it into feasible 6-month goals with specific experiments, datasets, architectures, and metrics, aligning well with Stage C research planning and acting as a supportive mentor. However, it has minor flaws including truncation in Experiment 4, which leaves the plan incomplete, and assumptions about access to advanced resources like hospital partnerships and in vitro validation without addressing the user's unknown expertise or providing scaled-down alternatives. Overall, it equips the user with clear direction and expert guidance, with only slight uncertainties in feasibility.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6702,
            "output_tokens": 766,
            "total_tokens": 7468,
            "input_token_details": {
              "audio": 0,
              "cache_read": 148
            },
            "output_token_details": {
              "reasoning": 630
            }
          },
          "score": 1.75
        }
      ]
    },
    "evidence_integrity": {
      "score": 0.0,
      "details": {
        "reason": "invalid_citations",
        "zeroed_metrics": [
          "citation_relevance",
          "citation_quality"
        ]
      }
    }
  },
  "judge_models": [
    "openrouter:qwen/qwen3-max",
    "openrouter:deepseek/deepseek-v3.2-exp",
    "openrouter:x-ai/grok-4-fast"
  ],
  "output_label": "stage_a_claude_icml",
  "metrics_version": 2,
  "metrics_config_digest": "a31bad517a27358a8cb4d2358e65893663baa28bc7c41094fbf9d18d0ca1ed6c",
  "judge_prompt_digest": "afa86426f4e1190c7e32d79e00ab44a8d0a8f0d7214d1b468f67d1e55805dea5",
  "citation_domains_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367",
  "metric_prompt_digests": {
    "rag_fidelity": "660c53926744ab90570c53c1f01f95a01418055d91d2d572548404a03d341213",
    "citation_relevance": "98e8253bb21908885984e8b0e785770109f8ba9d552643caf8ba1e3374ad890a",
    "source_fit": "52b3a41c4befe563c4dad55f6bd214485f3cc0131b5cf012675c50494bf7dcfc",
    "citation_quality": "5259dca527f992d0505c3ee9b5c3462b2a12897e148dbccd09312c272e4bf63d",
    "clarification_quality": "3b183f9c89bb5886e63ecb31dc1007295b4f8947ea6d6bbd32a23079fc4af31f",
    "actionability": "8a22150e502c7ab6cfdddb1d3d1c099843fa4842396eb2636788a60c2946d86d",
    "persona_compliance": "c27b9859c4cc18a4f43399259b5ffdb58e8c26904250229e6f92898eaf88ab18",
    "stage_awareness": "5b1b7f17ec0646db3d593e6dd649d1071bd6192f0ce5f23634ba8c3d467eef81",
    "tone_constructive": "8fc396d1c769b5f346ff7ebb6233623f7632cb0ef576ab0219b2c3d2ca4b3e8b",
    "expectation_management": "537d0916b79eefb7a55b23ef48d10cc981035067109054d7e29e04fe4e91470f",
    "plan_completeness": "f7d0e4d18670ffd18d4fb2b6c2b1f1db75a52b6f49956113b079dd6ff44e315f",
    "risk_mitigation": "0d372e749228777994b8302c4f4da77820fd56fa3bb11982a274fa3a3ec9f5a8",
    "feasibility_analysis": "1641c449a082419af5efdc972d708b763f96f0567dc9144a7ae89365076782b4",
    "holistic_score": "6cdb02446585ab2dd7721b38d784cf3e3ea655e061c6eebacff75052b39f6f60"
  },
  "model_params": {
    "temperature": 0.0,
    "max_output_tokens": null,
    "seed": null
  },
  "model_spec": {
    "provider": "openrouter",
    "model": "anthropic/claude-sonnet-4.5",
    "system_id": "openrouter:anthropic/claude-sonnet-4.5",
    "system_alias": "openrouter-anthropic_claude-sonnet-4.5"
  },
  "expected_checks": [
    "tool_routing",
    "rag_fidelity",
    "fallback_robustness",
    "citation_validity",
    "citation_relevance",
    "source_fit",
    "citation_quality",
    "clarification_quality",
    "actionability",
    "persona_compliance",
    "stage_awareness",
    "tone_constructive",
    "expectation_management",
    "plan_completeness",
    "risk_mitigation",
    "feasibility_analysis",
    "holistic_score"
  ],
  "judge_parameters": [
    {
      "spec": "openrouter:qwen/qwen3-max",
      "temperature": 0.0,
      "max_tokens": 1536
    },
    {
      "spec": "openrouter:deepseek/deepseek-v3.2-exp",
      "temperature": 0.0,
      "max_tokens": 1536
    },
    {
      "spec": "openrouter:x-ai/grok-4-fast",
      "temperature": 0.0,
      "max_tokens": 1536
    }
  ]
}